Premium
Private equity firm Everstone Capital is in negotiations to invest in a pharmaceutical company, two people familiar with the matter...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
